Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Child Development Disorders, Pervasive

• A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder
• Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial
• Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
• Esketamine and Propofol for Children With Autism Spectrum Disorder Undergoing Colonoscopy
• ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)
• Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study.
• Oxytocin Effects on Bone Metabolism in Children With Autism Spectrum Disorder
• A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder
• Psilocybin in Adults With and Without Autism Spectrum Disorder
• Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder
• Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
• Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder.
• Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum Disorder
• Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASD
• Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
• SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)
• ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
• A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum Disorder
• Biomarker-Driven Pharmacological Treatment of Adolescents With Autism Spectrum Disorder With Gabapentin
• Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder
• Application of Fecal Microbiota Transplantation in Children With ASD
• AB-2004 in Treatment of Adolescents With Irritability Associated With Autism Spectrum Disorder (ASD)
• Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder
• Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders
• Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder
• Effect of Lithium in Patients With Autism Spectrum Disorder and Phelan-McDermid Syndrome (SHANK3 Haploinsufficiency)
• CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants
• A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)
• Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148
• Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder
• Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium
• A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Balovaptan in Children With Autism Spectrum Disorder
• Propranolol for Challenging Behaviors in Autism
• A Proof-of-Concept Study of Minocycline in Autism
• Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder
• Cannabidiol for ASD Open Trial
• Therapeutic Issues for Autism
• Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder
• Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)
• From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1
• Folinic Acid in Autism
• Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
• Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
• Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
• Arbaclofen in Children and Adolescents With ASD
• GABA Pathways in Autism Spectrum Disorder (ASD)
• A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum Disorder
• Modulation of the Brain Excitatory/Inhibitory (E/I) Balance in Autism Spectrum Disorder (ASD)
• Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin
• Fatty Acid Supplementation in Children With ASD
• Improving Driving in Young People With Autism Spectrum Disorders
• Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder
• Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
• A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension
• A Trial of TTA-121 on Autism Spectrum Disorder
• Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder
• A Pilot Study of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
• Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders
• Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
• Probiotics and Oxytocin Nasal Spray on Social Behaviors of Autism Spectrum Disorder (ASD) Children
• Specifying and Treating Anxiety in Autism Research
• Intranasal Vasopressin Treatment in Children With Autism
• Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
• Treatment of Encopresis in Children With Autism Spectrum Disorders
• A Study of Bumetanide for the Treatment of Autism Spectrum Disorders
• Measuring Brain Inflammation in Autism
• Autism Oxytocin Brain Project
• A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder
• A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
• Neural and Behavioral Effects of Oxytocin in Autism Spectrum Disorders
• Oxytocin and Social Cognitive Skills Groups
• Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
• Probiotics for Quality of Life in Autism Spectrum Disorders
• A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
• Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response
• Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder
• Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder
• Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance Spectroscopy
• Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders
• Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
• Pilot Trial of Pregnenolone in Autism
• Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder
• Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders
• Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)
• Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism
• Folinic Acid in Children With Autism Spectrum Disorders
• Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders
• Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder
• A Trial of Sertraline in Young Children With Autism Spectrum Disorder
• Cortical Metrics Assessment Outcome Measure Development in Autism With Memantine Treatment
• Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)?
• Dyad Oxytocin Study (DOS)
• An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
• Cortical Metrics in Intervention Trials With Autism Spectrum Disorders
• An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
• Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
• Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
• Oxytocin in Adolescents With Autism Spectrum Disorders
• Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder
• A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
• Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
• An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
• A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder
• Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
• An Open-Label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
• Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
• A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
• INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders
• Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
• TSO in Pediatric Autistic Spectrum Disorders
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
• Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders
• Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
• A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD
• A Folinic Acid Intervention for Autism Spectrum Disorders
• An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
• Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
• Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
• Intranasal Oxytocin and Learning in Autism
• Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
• Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
• Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders
• A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
• Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
• Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
• Intranasal Oxytocin for the Treatment of Children and Adolescents With ASD (OXY)
• Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders
• Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
• Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)
• Multidimensional Measurement of Psychopharmacological Treatment Response
• A Study of Divalproex Sodium in Children With ASD and Epileptiform EEG
• Brain Imaging Study of Adults With Autism Spectrum Disorders
• D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
• Memantine in Adult Autism Spectrum Disorder
• An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders
• Trichuris Suis Ova in Autism Spectrum Disorders
• Melatonin CR for the Treatment of Impaired Sleep Maintenance in 4-8 Year Old Children With Autism Spectrum Disorders
• FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders
• Efficacy and Safety of Lenalidomide for Treatment of Autistic Spectrum Disorders
• Study of Fluconazole in Children With Autism Spectrum Disorder
• A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
• Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
• Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders
• Atomoxetine, Placebo and Parent Management Training in Autism
• Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
• Study of Aripiprazole to Treat Children and Adolescents With Autism
• Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders
• A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
• Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
• Mercury Chelation to Treat Autism
• Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism
• Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
• An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)
• Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders
• Metabolic Effects of Antipsychotics in Children
• A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
• Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
• Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)
• Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
• RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders
• Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders